Wheeldon, L.; Jones, M.; Probyn, B.; Shetty, D.; Garvican, J.
Use of the Biocartis Idylla™ Platform for the Detection of Epidermal Growth Factor Receptor, BRAF and KRAS Proto-Oncogene Mutations in Liquid-Based Cytology Specimens from Patients with Non-Small Cell Lung Carcinoma and Pancreatic Adenocarcinoma. J. Mol. Pathol. 2022, 3, 104-114.
https://doi.org/10.3390/jmp3020010
AMA Style
Wheeldon L, Jones M, Probyn B, Shetty D, Garvican J.
Use of the Biocartis Idylla™ Platform for the Detection of Epidermal Growth Factor Receptor, BRAF and KRAS Proto-Oncogene Mutations in Liquid-Based Cytology Specimens from Patients with Non-Small Cell Lung Carcinoma and Pancreatic Adenocarcinoma. Journal of Molecular Pathology. 2022; 3(2):104-114.
https://doi.org/10.3390/jmp3020010
Chicago/Turabian Style
Wheeldon, Leonie, Mary Jones, Ben Probyn, Dushyant Shetty, and James Garvican.
2022. "Use of the Biocartis Idylla™ Platform for the Detection of Epidermal Growth Factor Receptor, BRAF and KRAS Proto-Oncogene Mutations in Liquid-Based Cytology Specimens from Patients with Non-Small Cell Lung Carcinoma and Pancreatic Adenocarcinoma" Journal of Molecular Pathology 3, no. 2: 104-114.
https://doi.org/10.3390/jmp3020010
APA Style
Wheeldon, L., Jones, M., Probyn, B., Shetty, D., & Garvican, J.
(2022). Use of the Biocartis Idylla™ Platform for the Detection of Epidermal Growth Factor Receptor, BRAF and KRAS Proto-Oncogene Mutations in Liquid-Based Cytology Specimens from Patients with Non-Small Cell Lung Carcinoma and Pancreatic Adenocarcinoma. Journal of Molecular Pathology, 3(2), 104-114.
https://doi.org/10.3390/jmp3020010
